Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are barely eating on Wegovy, you are not alone, and the reduced appetite is partly the point — but eating too little for too long creates its own problems. Wegovy (semaglutide) suppresses hunger significantly, and for some people that crosses a line from helpful into genuinely insufficient. The decision in front of you is not whether to push through hunger, but whether what you are eating is giving your body what it needs to lose weight well, not just fast. These are prescription-only medicines requiring ongoing clinical oversight, so any concern about your intake is worth raising with your prescriber rather than solving alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy works, in large part, by making food feel less urgent. Most people on treatment eat less than before, that is expected and, for weight management, useful. The question worth asking yourself honestly is whether your reduced intake is sustainable or whether it has tipped into something that leaves you running on empty. There is a common misconception that eating as little as possible must mean faster results. It does not. Below a threshold that varies by body size and activity level, the body begins to draw on muscle tissue alongside fat, and weight loss of that kind is not what the treatment is designed to achieve.
A practical way to think about it: if you are managing three small meals or two meals and a snack, drinking enough fluid, and feeling tired but functional, that is probably reduced appetite doing its job. If you are going whole days on very little, feeling faint or too fatigued to concentrate, losing hair in noticeable amounts, or struggling to take in any solid food, something needs to change. The general guidance on eating on Wegovy sets out what a sensible daily pattern looks like in more detail.
Protein is the nutrient most at risk when appetite falls sharply. Muscle mass is partly maintained through dietary protein, and if you are eating very little overall, protein is almost certainly falling short. Research consistently shows that rapid weight loss with inadequate protein accelerates the proportion of lean mass lost, which can slow your resting metabolism and make weight maintenance harder later. Aim for protein at every meal, even if the portions are small: eggs, fish, chicken, Greek yogurt, pulses. The practical guidance on what to eat on Wegovy gives concrete food suggestions that fit smaller appetites.
Micronutrients matter too. A very restricted diet can run low on iron, B vitamins, zinc and calcium, none of which announce themselves immediately but all of which affect energy, hair, immunity and bone health over weeks and months. The structured eating plan for people on Wegovy covers how to prioritise nutrient density when volume is limited. The NHS's guidance on weight-management injections also notes that appropriate dietary support is considered an essential part of treatment, not an optional extra.
Nausea is the most common reason people on Wegovy barely eat in the days after a dose increase. It tends to be most pronounced in the 24–48 hours after the injection and usually settles within a week or two as the body adjusts. That temporary dip in intake is different from a sustained pattern of eating far too little. If nausea is the driver, small bland meals, cold foods (which smell less), and eating slowly tend to help more than skipping meals entirely. The practical approaches to eating while on Wegovy covers this in full.
If the problem is not nausea but simply no hunger signal at all, that can be harder to manage because there is no discomfort pushing you to act. Scheduling meals rather than waiting for appetite is a practical strategy many people find useful, treating food as a commitment rather than a cue. The broader discussion of not eating on Wegovy addresses what to do when appetite disappears rather than just diminishes. The NHS's patient-level information on semaglutide also notes that persistent vomiting or inability to eat and drink should be reported to a healthcare professional promptly.
A prescriber has real options when intake becomes a clinical concern. Staying at the current dose longer rather than titrating up gives the body more time to adapt and often brings appetite back to a manageable level. In some cases a dose reduction is appropriate, particularly if the suppression is severe. Neither of those decisions needs to feel like failure, dose flexibility is built into how Wegovy is used, and the prescriber's job is to make treatment work for you specifically, not to move through a schedule regardless of how you are tolerating it.
If you are considering starting treatment or would like a clinical view on how your current intake sits with your dose, a consultation through a regulated service is the right starting point. At nume, every consultation is read by a GPhC-registered prescriber on the day it comes in, a real clinician, not automated processing. The full Wegovy overview explains the treatment in detail, and for a broader look at your options, the weight-loss treatments overview covers what is available. Check your eligibility to speak with our prescribers if you have questions about your intake or your dose.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.